Mutated immunoglobulin-binding polypeptides
AssigneeCytiva BioProcess R&D AB
InventorsGustav RODRIGO, Tomas Bjorkman, Mats Ander
Life of this patent
Estimating the term…
Abstract
An Fc-binding polypeptide of improved alkali stability, comprising a mutant of an Fc-binding domain of Staphylococcus Protein A (SpA), as defined by SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 22, SEQ ID NO 51 or SEQ ID NO 52 wherein at least the asparagine or serine residue at the position corresponding to position 11 in SEQ ID NO: 4-7 has been mutated to an amino acid selected from the group consisting of glutamic acid, lysine, tyrosine, threonine, phenylalanine, leucine, isoleucine, tryptophan, methionine, valine, alanine, histidine and arginine.
Claims20
1-49. (canceled)
A polypeptide capable of binding to an Fc region of an antibody, wherein the polypeptide comprises at least one monomeric unit comprising the amino acid sequence of SEQ ID NO:
- 11.
A polypeptide capable of binding to an Fc region of an antibody, wherein the polypeptide comprises four monomeric units, each monomeric unit comprising the amino acid sequence of SEQ ID NO:11.
Dependencies are inferred from the claim text.